TRIAMCINOLONE ACETONIDE INJECTABLE SUSPE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F8154 to DMS Pharmaceutical Group Inc on July 24, 2026, for the procurement of Triamcinolone Acetonide Injectable Suspension. This delivery order, issued under the broader base contract SPE2DX25D9900 managed by the DLA Troop Support Medical Supply Chain, totals 171.85 for five units at a unit price of 34.37. The supplies are scheduled for delivery to Fort Bragg, North Carolina, by August 10, 2026. The procurement falls under NAICS code 424210 and is associated with National Stock Number 6505012104472. The overarching base contract, which has a total value of 19,999,999.00, incorporates standard federal regulations including FAR clause 52.222-50 regarding Combating Trafficking in Persons.
General Info
Contract Value
$171.85Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
